The Finnish trial of prostate cancer screening: where are we now?-Reference-Cited by-同舟云学术

The Finnish trial of prostate cancer screening: where are we now?

Published:2003-12 Issue:s2 Volume:92 Page:22-26
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Finne P.,Stenman U.-H.,Maattanen L.,Makinen T.,Tammela T.L.J.,Martikainen P.,Ruutu M.,Ala-Opas M.,Aro J.,Karhunen P.J.,Lahtela J.,Rissanen P.,Juusela H.,Hakama M.,Auvinen A.

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1465-5101.2003.04397.x/fullpdf

Reference24 articles.

1. European randomized study of prostate cancer screening: first-year results of the Finnish trial

2. Large-scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

3. How to improve prostate biopsy detection of prostate cancer

4. Guidelines for processing and reporting of prostatic needle biopsies

5. Three-Year Results of the Finnish Prostate Cancer Screening Trial

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Does Protocol Make a Difference? Comparison of Two Prostate Cancer Active Surveillance Cohorts: A Non–protocol-based Follow-up and a Protocol-based Contemporary Follow-up;European Urology Open Science;2021-12

2. Novel prostate cancer susceptibility gene SP6 predisposes patients to aggressive disease;Prostate Cancer and Prostatic Diseases;2021-05-19

3. Sojourn-time-corrected receiver operating characteristic curve (ROC) for prostate specific antigen (PSA) test in population-based prostate cancer screening;Scientific Reports;2020-11-26

4. Prostate cancer risk prediction using a polygenic risk score;Scientific Reports;2020-10-13

5. Number of screening rounds attended and incidence of high‐risk prostate cancer in the Finnish Randomized Study of Screening for Prostate Cancer (FinRSPC);Cancer;2020-10-13